The benchmark S&P/ASX 200 (Index: ^AXJO) (ASX: XJO) has had a positive start to the week and in early afternoon trade is up 0.15% to 6,130 points.
Four shares climbing more than most today are listed below. Here's why they started the week with a bang:
The Argosy Minerals Limited (ASX: AGY) share price has jumped 14% to 40 cents. Investors have been fighting to get hold of its shares due to the potential of its Rincon Lithium Project in Argentina. In fact, demand has been so strong for its shares that they rose over 1,000% last year. I think Argosy has a lot of promise and is worth keeping a close eye on.
The Auscann Group Holdings Ltd (ASX: AC8) share price has continued its impressive performance with another move higher. The medicinal cannabis company's shares are up 12.5% to $1.79, bringing its year-to-date gain to an incredible 125%. Whilst I am a big fan of AusCann, I'd be careful buying in at the current share price.
The Cochlear Limited (ASX: COH) share price has risen almost 2% to $175.21 following the release of a positive broker note out of Morgan Stanley. The broker has upgraded its price target on Cochlear to $164 from $146. This is, however, still well below the current share price. I would suggest investors wait in hope of a pull-back to around $150.
The Vocus Group Ltd (ASX: VOC) share price has charged 3.5% higher to $3.25. Although not major news, this morning Vocus announced the appointment of Mr John Ho as a non-executive director. Mr Ho is the founder and chief investment officer of Janchor Partners, a long-term industrialist investor based in Hong Kong. He indirectly holds a 17.9% stake in Vocus.
